Pharmaceutical Technology's Annual Employment Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology's Annual Employment Survey
Nearly 1300 pharmaceutical employees provide insights into the issues most relevant to their jobs and the state of the industry workforce today.


Pharmaceutical Technology



Table III.Percentage of respondents receiving the following employer-provided benefits.
Benefits. The most common benefits include health insurance; dental, vision, or supplemental health insurance; life insurance; and employer-provided 401k match contributions (see Table III). Approximately 70% of employees also receive reimbursement for supplemental training or conference attendance.

On average, employees are granted 10 paid public holidays and 18 paid vacation days, though most took only 15 of these days for vacation and admitted to doing some work (e.g., checking e-mail, returning calls) for at least 4 of these days (one more day than last year).

Attitudes toward current employment

Participants indicated how strongly they agreed or disagreed with the following statements:
  • I believe my work is fully valued by my employer.
  • I believe my present job is secure.
  • In my present job, I use my skills and training to the fullest extent.
  • Given the opportunity, I would leave my present job.


Table IV: Opinions toward current employment.
Most respondents feel secure in their jobs, agree that their employer values their work, and believe that they use their skills to the fullest extent in their present jobs (see Table IV). Nonetheless, 38% either agreed or strongly agreed that they would leave their present job if given the opportunity, this is a sharp contrast to the 53% who responded the same last year. Employees seem less willing to leave their job in a less secure job market. Last year, 68% felt their job was secure, while this year, this value is only 60%.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here